Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ANTITHYMOCYTE IMMUNOGLOBULIN Cause Graft versus host disease? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Graft versus host disease have been filed in association with ANTITHYMOCYTE IMMUNOGLOBULIN. This represents 12.4% of all adverse event reports for ANTITHYMOCYTE IMMUNOGLOBULIN.

10
Reports of Graft versus host disease with ANTITHYMOCYTE IMMUNOGLOBULIN
12.4%
of all ANTITHYMOCYTE IMMUNOGLOBULIN reports
7
Deaths
1
Hospitalizations

How Dangerous Is Graft versus host disease From ANTITHYMOCYTE IMMUNOGLOBULIN?

Of the 10 reports, 7 (70.0%) resulted in death, 1 (10.0%) required hospitalization.

Is Graft versus host disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ANTITHYMOCYTE IMMUNOGLOBULIN. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does ANTITHYMOCYTE IMMUNOGLOBULIN Cause?

Acute graft versus host disease (22) Autoimmune haemolytic anaemia (12) Acute lymphocytic leukaemia recurrent (10) Chronic graft versus host disease (10) Drug ineffective (10) Therapeutic response decreased (10) Thrombocytopenia (6) Acute myeloid leukaemia recurrent (5) Epstein-barr virus infection (5) Post transplant lymphoproliferative disorder (5)

What Other Drugs Cause Graft versus host disease?

CYCLOSPORINE (1,131) TACROLIMUS (900) MYCOPHENOLATE MOFETIL (890) CYCLOPHOSPHAMIDE (653) METHOTREXATE (615) FLUDARABINE (541) BUSULFAN (507) RUXOLITINIB (469) METHYLPREDNISOLONE (429) PREDNISONE (405)

Related Pages

ANTITHYMOCYTE IMMUNOGLOBULIN Full Profile All Graft versus host disease Reports All Drugs Causing Graft versus host disease ANTITHYMOCYTE IMMUNOGLOBULIN Demographics